Bicisate: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Bicisate. Educational only — not medical advice.

Labeled uses

NEUROLITE® single photon emission computerized tomography (SPECT) is indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed. NEUROLITE® is not indicated for assessment of functional viability of brain tissue. Also, NEUROLITE® is not indicated for distinguishing between stroke and other brain lesions.

Source: FDA labeling via NIH DailyMed (set e2c9efae…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.